Provided by Tiger Trade Technology Pte. Ltd.

DexCom

62.25
-3.8400-5.81%
Post-market: 61.99-0.2600-0.42%19:35 EDT
Volume:4.31M
Turnover:270.27M
Market Cap:23.96B
PE:29.79
High:65.91
Open:65.91
Low:61.99
Close:66.09
52wk High:89.98
52wk Low:54.11
Shares:384.86M
Float Shares:382.00M
Volume Ratio:1.04
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.09
EPS(LYR):2.09
ROE:34.50%
ROA:8.89%
PB:8.72
PE(LYR):29.79

Loading ...

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

THOMSON REUTERS
·
Jan 07

DexCom Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jan 06

Reassessing DexCom (DXCM): Is the Market Underestimating Its Valuation After a Year of Weaker Share Price Performance?

Simply Wall St.
·
Jan 05

It’s Earnings Warning Season. How to Profit From Others’ Misery

Dow Jones
·
Jan 01

DexCom Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Jan 01

BRIEF-FDA Says Dexcom Issues Correction For Dexcom G6 And G6 Pro Software

Reuters
·
Dec 30, 2025

FDA- Dexcom Issues Correction for Dexcom G6 and G6 Pro Software

THOMSON REUTERS
·
Dec 30, 2025

DexCom Faces Class Action Lawsuit Alleging Securities Fraud

Reuters
·
Dec 23, 2025

DexCom Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Dec 23, 2025

DexCom Awards New CEO Jacob Leach $1.15 Million Salary and $15 Million Equity Package

Reuters
·
Dec 23, 2025

BUZZ - Nasdaq top and bottom performing stocks at about 11:13 a.m. EST on 2025-12-22

Reuters
·
Dec 23, 2025

DexCom Faces Investor Class Action Over Alleged Securities Fraud

Reuters
·
Dec 20, 2025

3 Stocks Estimated To Be Undervalued By Up To 48.3%

Simply Wall St.
·
Dec 20, 2025

Dexcom (DXCM): Valuation Check After Launch of Dexcom Academy for EMEA Healthcare Professionals

Simply Wall St.
·
Dec 18, 2025

DexCom Faces Class Action Lawsuit Over Alleged False Statements on Glucose Monitor Safety

Reuters
·
Dec 17, 2025

Leerink Partners Adjusts Price Target on DexCom to $92 From $81, Maintains Outperform Rating

MT Newswires Live
·
Dec 16, 2025

FDA Warns DexCom Over Unapproved Sensor Changes in G6 and G7 Devices

Reuters
·
Dec 16, 2025

Dexcom Inc : Leerink Partners Raises Target Price to $92 From $81

THOMSON REUTERS
·
Dec 16, 2025

DexCom Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Dec 16, 2025

Liberty All-Star Equity Fund Announces November 2025 Portfolio Update

Reuters
·
Dec 16, 2025